Biden's Inflation Reduction Act continues to rattle big pharma as ten targeted drugs revealed 31-Aug-2023 By Liza Laws The moment that major pharma companies have been dreading, since the approval of Biden's Inflation Reduction Act, has arrived.
‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate 23-Mar-2023 By Rachel Arthur The UK BioIndustry Association has welcomed a new enhanced R&D tax relief rate, announced in the government’s Spring Budget last week.
Lilly: Tax reforms would release $150m to further support US manufacturing 27-Mar-2017 By Dan Stanton Eli Lilly will invest $850m in its US operations this year but warns the country’s antiquated tax system leaves the firm at a competitive disadvantage.